This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eric D. Donnenfeld, MD; Henry D. Perry, MD; Robert W. Snyder, MD; Ken Moadel, MD; Mitch Elsky; Hanifa Jones, MD

Arch Ophthalmol. 1997;115(2):173-176.

Abstract
Objectives
To investigate the intracorneal, aqueous, and vitreous penetration of ofloxacin, and to assess the concentration of the drug after topical administration alone and after combined topical and oral administration.

Methods
Twenty consecutive patients undergoing penetrating keratoplasty with vitrectomy for bullous keratopathy received 2 drops of 0.3% ofloxacin every 30 minutes starting 4 hours before surgery. Group A (10 patients) received topical therapy alone. Group B (10 patients) received an additional 3 doses of oral ofloxacin, 400 mg, every 12 hours starting 26 hours before surgery. Aqueous humor, vitreous humor, and corneal specimens were analyzed for ofloxacin levels.

Results
For group A, the mean intracorneal ofloxacin level was 4.51 µg/mL (range, 0.58-8.77 µg/mL; 10 specimens), the mean aqueous humor level was 1.34 µg/mL (range, 0.07-4.98 µg/mL; 8 specimens), and the mean vitreous humor level was 0.37 µg/mL (range, 0.05-0.90 µg/mL; 8 specimens). For group B, the mean intracorneal ofloxacin level was 8.59 µg/mL (range, 1.18-23.24 µg/mL; 10 specimens), the mean aqueous humor level was 2.77 µg/mL (range, 0.25-5.80 µg/mL; 10 specimens), and the mean vitreous humor level was 2.55 µg/mL (range, 0.28-4.97 µg/mL; 9 specimens).

Conclusions
Topically applied ofloxacin achieves therapeutic levels in the cornea and aqueous. Mean levels achievable are well above the 90% minimal inhibitory concentration (MIC₉₀) for the majority of bacteria responsible for endophthalmitis and corneal ulceration. The addition of oral ofloxacin to topical therapy increased vitreous penetration 7-fold in this assay trial.

Author Affiliations
From the Department of Ophthalmology, North Shore University Hospital, Manhasset, NY, and Cornell University Medical College, New York, NY (Drs Donnenfeld, Perry, and Moadel and Mr Elsky), and the Department of Ophthalmology, University of Arizona, Tucson (Drs Snyder and Jones).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Concentration and Bioavailability of Ciprofloxacin and Teicoplanin in the Cornea
Kaye et al.
IOVS 2009;50:3176-3184.
ABSTRACT | FULL TEXT  

Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial
Cantor et al.
Br J Ophthalmol 2008;92:345-347.
ABSTRACT | FULL TEXT  

Levofloxacin Disposition over Time in Aqueous Humor of Patients Undergoing Cataract Surgery
Pea et al.
Antimicrob. Agents Chemother. 2005;49:2554-2557.
ABSTRACT | FULL TEXT  

Penetration of moxifloxacin into the human aqueous humour after oral administration
Kampougeris et al.
Br J Ophthalmol 2005;89:628-631.
ABSTRACT | FULL TEXT  

193-nm Excimer Laser-Induced Fluorescence Detection of Fluoroquinolones in Rabbit Corneas
Chuck et al.
Arch Ophthalmol 2004;122:1693-1699.
ABSTRACT | FULL TEXT  

Vitreous penetration of levofloxacin in the uninflamed phakic human eye
Herbert et al.
Br J Ophthalmol 2002;86:387-389.
ABSTRACT | FULL TEXT  

Penetration of Ofloxacin and Ciprofloxacin Into the Aqueous Humor of Eyes With Functioning Filtering Blebs: A Randomized Trial
Cantor et al.
Arch Ophthalmol 2001;119:1254-1257.
ABSTRACT | FULL TEXT  

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid
Çekiç et al.
Br J Ophthalmol 1999;83:1183-1185.
ABSTRACT | FULL TEXT